Amwill Healthcare: Amwill Healthcare shares get listed at 20% discount!Amwill Healthcare: Amwill Healthcare shares get listed at 20% discount!

Amwill Healthcare’s shares had a weak debut on February 12, listing at ₹88.85 on the BSE SME platform, marking a 20% discount from the issue price of ₹111. The stock’s performance fell short of market expectations on its first trading day.

Also Read: Defence stock in focus after it signs agreement with Troop Comforts for air-defence system

Amwill Healthcare’s ₹60 crore SME IPO was open for subscription from February 5 to 7, 2025, at ₹111 per share. It included a fresh issue of ₹48.88 crore and an offer for sale of ₹11.10 crore. The IPO saw 5.73x overall subscription, with QIBs leading at 7.8x.

Amwill Healthcare is a derma-cosmetic development company specializing in contract manufacturing, distribution, and third-party product development. Focused on dermatological and aesthetic solutions, it emphasizes formulation and innovation while outsourcing manufacturing, prototype development, and distribution to third-party providers for streamlined operations and market efficiency.

Also Read: PSU stock jumps after it receives order worth ₹270 Cr

The objective of Amwill Healthcare’s IPO is to fund business expansion, working capital requirements, and general corporate purposes. The fresh issue proceeds will support growth initiatives, while the offer for sale allows existing shareholders to partially exit and unlock value.

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.